Improve your Understanding and Modelling of Drug Transporters to Better Predict Drug-Drug Interactions, Enhance Interaction Study Efficiency and Increase Drug Efficacy
Since the publication of the much-anticipated International Transporter Consortium white paper, there has been much industry and academic debate as to its content and impact on the field of transporters. This conference will provide pharmaceutical professionals with the first opportunity in Europe to discuss the content of the white paper and its impact on both you and your company with not only your peers and esteemed colleagues, but also 2 members of the ITC itself (Raymond Evers from Merck & and Caroline Lee from Pfizer). The conference is a high level forum that enables manufacturers to network and discuss the key challenges in this area such as the role of transporters in drug disposition and polymorphism, effective modelling techniques, the regulatory stance on transporters and discussion on the International Transporter Consortium (ITC) white paper.
Since the publication of the much-anticipated International Transporter Consortium white paper, there has been much industry and academic debate as to its content and impact on the field of transporters. This conference will provide pharmaceutical professionals with the first opportunity in Europe to discuss the content of the white paper and its impact on both you and your company with not only your peers and esteemed colleagues, but also 2 members of the ITC itself (Raymond Evers from Merck & and Caroline Lee from Pfizer). The conference is a high level forum that enables manufacturers to network and discuss the key challenges in this area such as the role of transporters in drug disposition and polymorphism, effective modelling techniques, the regulatory stance on transporters and discussion on the International Transporter Consortium (ITC) white paper.
